Sharad Sathyan, MD
Nephrology · Bloomfield, CTNPI 1508065681
Payments from drug & device makers
Across 346 payments — averaging $8232.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- CSL Behring$2.7M
- AstraZeneca$95K
- Astrazeneca UK Limited$39K
- Amgen$19K
- Travere Therapeutics, Inc.$16K
- Novartis$307
- plus $2K from 17 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| CSL Behring | 200 | $2,677,529 |
| AstraZeneca | 4 | $95,174 |
| Astrazeneca UK Limited | 1 | $39,107 |
| Amgen(2 entities) | 42 | $18,858 |
| Travere Therapeutics, Inc. | 39 | $15,599 |
| Novartis | 4 | $307 |
| Novo Nordisk | 8 | $292 |
| Baxter Healthcare | 3 | $267 |
| Medtronic | 3 | $229 |
| Aurinia Pharma U.S., Inc. | 7 | $183 |
| Otsuka America Pharmaceutical, Inc. | 3 | $145 |
| Akebia Therapeutics Inc | 6 | $137 |
| Vifor Pharma, Inc. | 6 | $108 |
| Mallinckrodt Hospital Products Inc. | 3 | $85 |
| GSK | 2 | $57 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 3 | $56 |
| Bayer | 3 | $53 |
| Fresenius USA Marketing, Inc. | 2 | $46 |
| Calliditas Therapeutics US Inc. | 2 | $44 |
| OPKO Pharmaceuticals, LLC | 2 | $34 |
| Lilly USA, LLC | 1 | $22 |
| Ardelyx, Inc. | 1 | $20 |
| Shire North American Group Inc | 1 | $15 |
How this compares
$2,848,366 in reported general payments places this provider in the 95th percentile of 144 nephrology providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other nephrology in Bloomfield
- Ari GellerBloomfield$526K
- Meghana GaikiBloomfield$254K
- Christine VigneaultBloomfield$54K
- Robert AlpernNew Haven$4.9M
- Jeffrey TurnerNew Haven$1.3M
- Sina RaissiMiddlebury$1.2M
- Aldo PeixotoNew Haven$362K
- Richard FormicaNew Haven$264K
- Fredric FinkelsteinNew Haven$136K
- Stefan SomloNew Haven$111K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.